- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Aerosolized, Recombinant Alpha 1-Antitrypsin
Total 2136 results
-
Instituto Grifols, S.A.Completed
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
Chiesi Farmaceutici S.p.A.ICON plcNot yet recruiting
-
Wright State UniversityTerminatedPneumonia, Ventilator-AssociatedUnited States
-
Ocera Therapeutics, Inc.No longer available
-
Blessing Corporate Services, IncTakeda Pharmaceuticals North America, Inc.Withdrawn
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Grifols Therapeutics LLCCompletedAlpha₁-Antitrypsin DeficiencyUnited States
-
OctapharmaWithdrawn
-
Inhibrx Biosciences, IncRecruitingEmphysema | Alpha 1-Antitrypsin DeficiencyUnited States, Australia, United Kingdom, New Zealand
-
Bio Sidus SARecruiting
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCCompletedMucopolysaccharidosis I | Scheie Syndrome | Hurler's Syndrome | Hurler-Scheie SyndromeBrazil, Canada
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCCompletedMucopolysaccharidosis I | Scheie Syndrome | Hurler Syndrome | Hurler-Scheie SyndromeJapan
-
agnes chenUniversity of California, Los Angeles; National Institute of Neurological Disorders... and other collaboratorsTerminatedMucopolysaccharidosis I | Cognitive DeclineUnited States
-
Chiesi Farmaceutici S.p.A.Completed
-
Zymenex A/SEuropean CommissionCompletedAlpha-MannosidosisBelgium, Denmark, Spain, United Kingdom
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCCompletedMucopolysaccharidosis I | Scheie Syndrome | Hurler Syndrome | Hurler-Scheie SyndromeNetherlands, France, Germany, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe DiseaseUnited States
-
Medical University of South CarolinaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedChronic PancreatitisUnited States
-
Chiesi Farmaceutici S.p.A.CompletedAlpha-MannosidosisFrance
-
Baxalta now part of ShireKamada, Ltd.TerminatedGraft Versus Host DiseaseUnited States
-
Soroka University Medical CenterUnknownPost Cardiac Surgery Systemic Inflammatory Response
-
Genzyme, a Sanofi CompanyBioMarin/Genzyme LLCTerminatedMucopolysaccharidosis I | Hurler's Syndrome | Hurler-Scheie Syndrome | ScheieItaly
-
Alexion PharmaceuticalsCompletedMucopolysaccharidosis IIIBUnited States, United Kingdom, Spain
-
Patricia I. Dickson, M.D.The Ryan FoundationTerminatedMucopolysaccharidosis I | Scheie Syndrome | Lysosomal Storage Disease | Spinal Cord Compression | Hurler-Scheie SyndromeFinland, United States
-
John LevineNational Cancer Institute (NCI)CompletedGVHD | Graft-versus-host-diseaseUnited States
-
Digna Biotech S.L.Unknown
-
Grifols Therapeutics LLCCompletedAlpha 1-Antitrypsin DeficiencyDenmark, Sweden, United Kingdom
-
Zensun Sci. & Tech. Co., Ltd.Recruiting
-
Stanford UniversityWithdrawnNeuromyelitis OpticaUnited States
-
Chiesi Farmaceutici S.p.A.ICON plcRecruiting
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Denmark, Belgium, United Kingdom, Norway, Italy, Czechia
-
Kafrelsheikh UniversityNot yet recruiting
-
Baxalta now part of ShireBaxalta Innovations GmbH, now part of ShireTerminatedChronic Obstructive Pulmonary Disease | Alpha1-antitrypsin DeficiencyUnited States, Canada, Australia
-
Columbia UniversityAlpha-1 Foundation; Stony Wold-Herbert Fund, Inc.CompletedChronic Obstructive Pulmonary Disease | Emphysema | Alpha-1 Antitrypsin DeficiencyUnited States
-
BioMarin PharmaceuticalCompletedBatten Disease | CLN2 Disease | Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 | Jansky-Bielschowsky Disease | CLN2 DisorderUnited States, Germany, Italy, United Kingdom
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Serbia, Spain, United Kingdom, Australia, Paraguay
-
ProtalixWithdrawn
-
Greenovation Biotech GmbHFGK Clinical Research GmbHCompleted
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Virginia Commonwealth UniversityCompletedAcute Myocardial InfarctionUnited States
-
Institute for Human Genetics and BiochemistryGrifols Biologicals, LLC; AIDS Community Research Initiative of AmericaTerminated
-
Hannover Medical SchoolCompletedKidney TransplantationGermany
-
BioMarin PharmaceuticalApproved for marketingCLN2 DiseaseUnited Kingdom, United States, Germany, Italy
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseAustralia, Netherlands, United Kingdom, Canada, Czechia, Norway, Slovenia
-
ProtalixChiesi Farmaceutici S.p.A.CompletedFabry DiseaseUnited States, Spain, United Kingdom, Paraguay
-
Assiut UniversityNot yet recruiting
-
Kamada, Ltd.CompletedTransplantation, Lung RejectionIsrael